Rheinmetall's Chief Buys the Dip While the Balance Sheet Waits for the Money to Arrive
Published on 11/07/2026 at 10:31 | Editorial boerse-global.de
Armin Theodor Papperger has put more of his own money behind Rheinmetall. Whether that personal conviction should carry weight with outside investors depends less on the purchase tickets than on a single operational question: can the defense group turn its enormous order book into cash before the funding strain becomes the story?
The CEO's latest transaction, disclosed in a mandatory filing, saw him acquire 249 shares through Tradegate at €804.40 apiece, for a total of €200,295.60. It followed a purchase of 585 shares on Xetra on Thursday, worth €502,484.40 at an average price of €858.9477. Two buys in quick succession, and a clear counterpoint to the more cautious tone management has adopted on the business.
A €78 Billion Backlog and a €1.7 Billion Cash Hole
The scale of the opportunity is not in doubt. Rheinmetall's order backlog stood at €78 billion at the end of September. What sits on the other side of the ledger is less comfortable: cumulative operating free cash flow over the first nine months came in at roughly minus €1.7 billion. The company has secured a vast pipeline of future business, but it must pre-finance a substantial share of it first.
That tension frames the investment case. Shareholders are effectively being asked to weigh whether the orders underwrite a later recovery, or whether delays tie up capital for longer than currently assumed. Papperger's open-market purchases are a personal vote of confidence; the cash flow statement will be the arbiter.
Should investors sell immediately? Or is it worth buying Rheinmetall?
The Cash Conversion Target Has Been Shelved
Rheinmetall still expects positive operating free cash flow for 2026, though capital expenditure is likely to exceed €1 billion. Set against the outflow booked so far, hitting that target requires a marked inflow over the remainder of the year. In the third quarter alone, operating free cash flow was minus €82 million. An advance payment received in October amounted to about €150 million — a useful illustration of how much hinges on the timing of customer money.
The company has abandoned its previous target of cash conversion above 40%. That raises the bar for actual receipts relative to earlier ambitions. A more favorable reading of the shares would need the expected improvement to show up in the ordinary course of business, not just in isolated prepayments.
Delays Are Piling Up on Several Fronts
The near-term drag is not confined to one program. Rheinmetall no longer expects the Boxer Arminius order this year; associated down payments and revenue are now slated for 2027. Acceptance delays on artillery ammunition are adding to the pressure, as are lower anticipated revenues from new activities, notably with Destinus.
On Wednesday the group cut its 2026 revenue guidance to around €13.2 billion, down from a previous range of €13.7–14.2 billion. The expected operating margin was trimmed too, to around 18.5% from roughly 19%. Any recovery therefore has to lift both the top line and its earnings contribution.
German price reviews on the Arminius contract loom large. According to media reports, approval is not expected before February 2027 at the earliest. Without that contract, Rheinmetall is likely to fall short of its targeted order volume by year-end.
What the Numbers Still Deliver
For all that, the underlying business is growing fast. Revenue for January to September 2026 reached €8.376 billion, up 38% year on year, with operating result of €1.339 billion and an operating margin of 16.0%. The third quarter alone contributed €3.149 billion in revenue and €553 million in operating result. Artillery ammunition deliveries for Ukraine and demand for air defense were among the drivers.
Quality supports the constructive case: 70% of the backlog consisted of firm orders at the end of September. If outstanding acceptances and contract signings can be pushed forward, that demand should convert into billable work — and, crucially, into the customer payments that fund the expansion.
Rheinmetall at a turning point? This analysis reveals what investors need to know now.
The Analyst Voice Cuts the Other Way
Not everyone is persuaded by the insider buying. Oddo BHF downgraded Rheinmetall yesterday from "Outperform" to "Neutral," cutting its price target to €1,200 from €1,670. The move pits a more circumspect analyst view against the chief executive's personal capital at risk.
That leaves investors weighing two signals of different kinds. Further slippage — whether on Arminius, munitions acceptances, or new activities — could overshadow the significance of the insider purchases if it dents revenue or margin expectations once again. Should even the reduced plan come under pressure, the bearish reading gains ground.
November's Capital Markets Day Is the Next Checkpoint
The announced capital markets day on 26–27 November 2026 is the nearest concrete date. What matters there is execution detail: how robust the Arminius timetable is, how munitions acceptances are progressing, what contribution new activities can make, and — just as important — when the money actually arrives and how investment spending is tracking.
Further out sits the expected 2027 decision on the XM30 program. For now, the proof will come from the existing book of business. If Rheinmetall improves its cash inflow, the recovery case strengthens. If delays stretch on, the financing requirement moves to center stage — and the chief executive's purchases will look less like a signal and more like a bet still waiting for confirmation.
Ad
Rheinmetall Stock: New Analysis - 7 November
Fresh Rheinmetall information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
